Rights and permissions
About this article
Cite this article
CancerVax Corporation temporarily halts enrolment in phase III melanoma trials. Inpharma Wkly. 1337, 4 (2002). https://doi.org/10.2165/00128413-200213370-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200213370-00008